Ownership history in NATIXIS · 8 quarters on record
This page tracks every 13F SEC filing in which NATIXIS reported a position in AXSOME THERAPEUTICS INC (AXSM). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | UNCHANGED | 485 | — | 0% | 0.00% | $59K | $121.45 |
| 2025 Q2 | REDUCED | 485 | -263 | -35.2% | 0.00% | $51K | $104.39 |
| 2024 Q4 | REDUCED | 748 | -142 | -16.0% | 0.00% | $63K | $84.61 |
| 2024 Q3 | REDUCED | 890 | -32,762 | -97.4% | 0.00% | $80K | $89.87 |
| 2024 Q2 | ADDED | 33,652 | +32,417 | +2624.9% | 0.02% | $2.7M | $80.50 |
| 2024 Q1 | ADDED | 1,235 | +148 | +13.6% | 0.00% | $99K | $79.80 |
| 2023 Q4 | REDUCED | 1,087 | -57 | -5.0% | 0.00% | $87K | $79.59 |
| 2023 Q3 | INITIATED | 1,144 | — | — | 0.00% | $80K | — |
As of 2025 Q4 — sorted by position size